| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |